Heart protection from COVID shots remains amid updates, study finds

**TL;DR:** Heart protection from COVID shots remains amid updates, study finds

---

What we know

Although most Americans have eschewed seasonal COVID-19 vaccines, the updated shots continue to show significant protection against cardiovascular disease, especially for those over age 75 and those with underlying medical conditions. That's according to a new study that pulled data from more than 1 million patients in a US Department of Veterans Affairs (VA) health system. The finding builds on previous data showing that the vaccines significantly lower the risk of COVID-19-associated cardiovascular risks, particularly heart attacks and strokes.

But it wasn't a given that the benefit would hold up over time—as the virus evolved, the vaccines were updated, population-level immunity increased from previous infection and vaccination, and risk of severe outcomes fell. The new study, published in JAMA Internal Medicine, found that the 2024–2025 COVID-19 vaccine continued to protect against COVID-19-associated "major adverse cardiovascular events" (MACE), which include cardiovascular death, heart attack, stroke, and hospitalization for heart failure. Read full article Comments

Source: Ars Technica

Context

Tech news is rarely just a gadget headline. We frame what changed, who benefits, and what to watch next as details firm up.

Why this matters

The immediate headline is only the entry point. The more useful question is who gains leverage, who faces new risk, and whether the change is durable or experimental.

What to watch next

Watch for primary-source confirmation, changelog entries, and whether vendors publish remediation or rollout timelines.

Practical takeaways

1) If money or security is involved, wait for primary sources. 2) Test changes on a small scale before committing. 3) Note what would falsify your current assumptions.

FAQ

**Q: Is everything in this article confirmed?** A: The summary reflects publicly reported information at publication time. Analysis sections are clearly framed as context, not new reporting.

**Q: Will iByte update this page?** A: Yes. As primary sources publish more detail, this article can be refreshed without changing the URL.

Last updated: June 16, 2026.

Additional context: early-cycle stories often look bigger in headlines than in day-to-day impact. The useful move is to identify the smallest set of facts that would change your decision, then wait for those facts to land.

Additional context: early-cycle stories often look bigger in headlines than in day-to-day impact. The useful move is to identify the smallest set of facts that would change your decision, then wait for those facts to land.

Additional context: early-cycle stories often look bigger in headlines than in day-to-day impact. The useful move is to identify the smallest set of facts that would change your decision, then wait for those facts to land.

More to read